Overview

Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and potential efficacy of a new drug, OT-730 ophthalmic solution (eye drops), in reducing intraocular pressure in the eyes of patients with open angle glaucoma or ocular hypertension. It will be compared with commercial timolol and placebo eye drops.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Othera Pharmaceuticals

Treatments:

Maleic acid
Ophthalmic Solutions
Pharmaceutical Solutions
Tetrahydrozoline
Timolol